201920182017201620152014 July 09, 2018 Summary ToggleSpero Therapeutics Announces Proposed Offering of Common Stock July 09, 2018 Summary ToggleSpero Announces Positive Interim Phase 1 SAD/MAD Results for SPR994 June 05, 2018 Summary ToggleSpero Therapeutics to Present New Preclinical Data for SPR994 at ASM Microbe 2018 June 01, 2018 Summary ToggleSpero Therapeutics to Present at the Jefferies 2018 Healthcare Conference in June May 23, 2018 Summary ToggleSpero Therapeutics Announces Positive Top-Line Data for Two Product Candidates from its Potentiator Platform May 10, 2018 Summary ToggleSpero Therapeutics Announces First Quarter 2018 Financial Results and Pipeline Update May 01, 2018 Summary ToggleSpero Therapeutics to Present at Bank of America Merrill Lynch Health Care Conference in May April 16, 2018 Summary ToggleSpero Therapeutics Highlights SPR741 Phase 1 and Preclinical Data at the 28th European Congress of Clinical Microbiology and Infectious Diseases April 12, 2018 Summary ToggleSpero Therapeutics Appoints Ian A. Critchley, Ph.D., as Head of Clinical Microbiology April 02, 2018 Summary ToggleSpero Therapeutics Announces Fourth Quarter and Full Year 2017 Operating Results and Provides Pipeline Update Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last
